Articles

  • Oct 11, 2024 | thehillnews.org | Alice Zhang

    An Open Letter to the UNTo Whom It May Concern:I sincerely hope your days have been wonderful while keeping your eyes shut on the struggles of the world, and I genuinely wonder if it makes you feel better choosing to turn blind to!-->!-->!-->!-->!-->…

  • Jun 5, 2024 | newsbreak.com | Alice Zhang

    Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.

  • Jun 5, 2024 | finance.yahoo.com | Alice Zhang

    Alice Zhang is CEO and cofounder of Verge Genomics. I started my biotech company Verge Genomics out of graduate school in 2015. We use artificial intelligence to treat some of today’s biggest unmet medical challenges, including ALS, Parkinson’s disease, and metabolic diseases.

  • Jun 4, 2024 | finance.yahoo.com | Alice Zhang

    Alice Zhang is CEO and cofounder of Verge Genomics. I started my biotech company Verge Genomics out of graduate school in 2015. Our north star is to leverage artificial intelligence and patient data to treat some of today’s biggest unmet medical challenges, including ALS, Parkinson’s disease, and dementia.

  • Mar 4, 2024 | mdpi.com | Linda Charmaraman |Alice Zhang |Kaitlyn Wang |Becky Chen

    All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →